Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp > Top 3 Canadian Biotech Stocks of 2022
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1176)
•••
Comment by Pandoraon Jul 20, 2022 8:52pm
100 Views
Post# 34838956

RE:RE:RE:Top 3 Canadian Biotech Stocks of 2022

RE:RE:RE:Top 3 Canadian Biotech Stocks of 2022
biorun wrote:
Recent Trades - Last 10 of 20
Time ET Ex Price Change Volume Buyer Seller Markers
15:42:23 M 0.21 0.01 100 80 National Bank 80 National Bank  
15:21:14 M 0.195 -0.005 167 7 TD Sec 1 Anonymous  
15:21:14 V 0.195 -0.005 500 2 RBC 2 RBC K
15:17:28 M 0.21 0.01 50 80 National Bank 80 National Bank E
14:50:31 V 0.20   3,500 79 CIBC 2 RBC K
14:50:31 H 0.20   5,500 1 Anonymous 2 RBC K
14:50:31 V 0.20   10,000 19 Desjardins 2 RBC K
14:50:31 V 0.20   1,000 1 Anonymous 2 RBC KL
14:50:31 O 0.20   5,500 1 Anonymous 2 RBC K
14:50:31 U 0.20   5,500 1 Anonymous 2 RBC K



Someone in Montreal is doing their best to support it above 20c. Not on the Venture!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities